NCT04447222View on ClinicalTrials.gov

Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors

Active, not recruitingOBSERVATIONAL
Enrollment

1,242

Participants

Timeline

Start Date

May 12, 2020

Primary Completion Date

July 30, 2026

Study Completion Date

July 30, 2026

Conditions
COVID-19 InfectionMalignant Solid Neoplasm
Interventions
OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Survey Administration

Complete survey

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER